Affiliated Organizations
The Ellison Institute has, as part of its mission, the goal of translating science for public benefit. We believe that consulting for and serving on the board of institutions of for-profit, non-profit, and government sectors is consistent with that mission. That said, we also believe in the importance of transparency and disclosure when these relationships exist and will report on this site any such relationships. When required, these relationships are reviewed and approved by USC to ensure compliance with university policy. Please be aware, however, that involvement by any member in these outside activities does not imply endorsement of the company, its products, or its services. You can find a list of those relationships below.

David B. Agus, MD

• Education Committee, American Society of Clinical Oncology, 2004-2009
• Biden Cancer Initiative, Founding Board of Directors, 2017- present
• Board of Directors, Medical Advisory Board, Oncology.com, Founder, 1998-2003
• Founder and Board of Directors, Navigenics, 2005-2013
• Founder and Board of Directors, Applied Proteomics, Inc., 2006-2016
• Founding Head, Grant/Science Review Committee, Accelerate Brain Cancer Cure (ABC2), 2001-2011
• Faculty, World Economic Forum, 2008-2019
• Technology Pioneers Committee, World Economic Forum, 2010-present
• Vice-Chair, Biotechnology Council, Network of Global Agenda Councils, Genetics & Summit on the Global Agenda, World Economic Forum, 2012-2015
• Chair, Genetics Council, Network of the Global Agenda Councils on Genetics and the Summit on the Global Agenda, World Economic Forum, 2011-2015
• Board of Advisors, TEDMED, 2011-2015
• Contributor, CBS News, 2013-present
• Member, Council on Foreign Relations, 2013-present
• Council on Foreign Relations, Non-communicable Disease Independent Task Force, 2013-2015
• National Library of Israel, Board of Directors, 2015- present
• Peres Center for Peace and Innovation, Board of Directors, 2015- present
• Trustee, Global Challenge Initiative on The Future of Health, World Economic Forum, 2016-present
• Osler Housestaff Advisory Board, Johns Hopkins Department of Medicine, 2016- present
• Board of Directors, Thrive Global, 2016-present
• Board of Directors, Crosschx, 2016-present
• Founder and Board of Directors, Project Ronin, 2018-present
• Founder and Board of Directors, Sensei, 2017-present

Anna Barker, PhD

• Presidential Appointee, Member, National Cancer Institute, National Institutes of Health, National Cancer Advisory Board, 2020 – present
• Chairman, Planning and Budget, National Cancer Institute, National Institutes of Health, National Cancer Advisory Board, 2020-present
• Distinguished Visiting Fellow, Complex Adaptive Systems, Arizona State University, 2019 – Present
• Professor of Practice, School of Life Sciences, Arizona State University, 2019 – Present
• Board of Trustees Member, Sanford Burnham Prebys Medical Discovery Institute, 2018-Present
• Board of Directors Members, Friends of Cancer Research, 2010 – Present
• Quantum Leap Healthcare, Board of Directors Member, 2010 – Present
• Scientific Advisory Board Member, Caris Life Sciences, 2014-Present
• SAGE Bionetworks, Scientific Advisory Board Member, 2018 – Present
• Precision Promise DSMB, Pancreatic Action Network Member, 2029 – Present
• Milken Institute, Cures Faster, Senior Fellow, 2015-Present
• American Association for Cancer Research (AACR), Founder and Chairman, Scientist- Survivor Program, 1999 – Present
• American Association for Cancer Research (AACR), Science Policy and Legislative Affairs Committee Member, 2010-Present
• American Association for Cancer Research, Chairman, Conflict of Interest Policies Committee, 2019-Present
• American Association for Cancer Research, Board of Scientific Advisors, 2010 – Present
• American Association for Cancer Research, Finance Committee Member, 2019-Present
• Quantum Leap Healthcare, Chairman, ISPY-2 and COVID – 19 ARDS Trials Oversight Committee 2010 – Present
• 21st Century Cures Act, Chairman, Biomarkers and Clinical Trials Working Group, 2018
• National Biomarker Development Alliance (NBDA), Co-Founder and Director, 2014 – 2019
• Biden Cancer Initiative, Chairman, Data Standards Group, 2017 – 2019
• American Association for Cancer Research, Annual Meeting, Program Committee, Co-Chairman Convergence Research Track, 2019
• Foundation for the National Institutes of Health, Biomarkers Consortium, Co-Chairman, Cancer Steering Committee, 2006-2010
• Foundation for the National Institutes of Health, ISPY-2 Planning Committee, (2007-2009)
• THE MARCH – Coming Together to Conquer Cancer – Vice Chairperson and Member of the Board of Directors, 1998 – 2000
• THE MARCH – Coming Together to Conquer Cancer, Co-Chairman, The March Research Task Force, Author March Task Force Report to Congress, 1998
• National Cancer Institute, National Institutes of Health, Division of Cancer Etiology, Board of Scientific Counselors, Member, 1986-90
• National Cancer Institute, National Institutes of Health, Cancer Center Support Review Committee, Member, 1976-79
• National Cancer Institute, National Institutes of Health, Cancer Center Support Review Committee, Chairperson, 1978-80
• National Cancer Institute, National Institutes of Health, Developmental Therapeutic Contracts Review Committee, Member, 1983-85
• National Cancer Institute, National Institutes of Health, Investigator Grants (OIG), Study Section, Member, July 1984
• National Cancer Institute, National Institutes of Health, Committee on Care and Use of Laboratory Animals, The National Academy of Sciences, Member, 1983-84
• National Cancer Institute, National Institutes of Health, Ad Hoc Construction Review Committee, Member, 1984-85
• USAMRDC Breast Cancer Research Program, Founder and Founding Integration Panel, Member, 1993- 2005
• USAMRDC Breast Cancer Research Program. Integration Panel, Chairperson, 1995-96
• USAMRDC Breast Cancer Research Program Integration Panel Chair Emeritus, 1997-99
• USAMRDC Breast Cancer Research Program Executive Committee Member, 1997- 2003
• USAMRDC Breast Cancer Research Program Era of Hope Meeting, Program Planning Committee Member, 1998, 2000, 2004
• C-change (National Dialogue on Cancer), Founding Member, Steering Committee, 1998
• C-change (National Dialogue on Cancer, Member, Board of Directors, 2001-2009
• C- Change (National Dialogue on Cancer Chairperson, NDC Cancer Research Team – 2000 - 2004
• C-change (National Dialogue on Cancer Collaborating Partner, 1999-2017
• C- Change (National Dialogue on Cancer) Member, Annual Meeting Planning Committee, 2007- 2017
• C- Change (National Dialogue on Cancer Co-Chairperson, Public Sector Research Team, 1999-2000
• American Association for Cancer Research, Board of Directors, 1999-2001
• American Association for Cancer Research, Board of Directors, 1995-1997
• American Association for Cancer Research, Science Policy and Legislative Affairs Committee (Public Education Committee), Chairperson, 1993-2003
• American Association for Cancer Research, Cancer Progress Report Committee, 2010-2016
• American Association for Cancer Research, Team Science Award Committee, 2016-2018
• American Association for Cancer Research, Margaret Foti Award for Extraordinary Leadership in Cancer Research Committee, 2017, 2019
• American Association for Cancer Research, Public Relations Committee, 1998-2002
• American Association for Cancer Research, Development Committee, 1991 – 2002
• American Association for Cancer Research, Development Committee, 1998-2002
• American Association for Cancer Research, Corporate Support Committee, Chairperson, 1991 – 1998
• American Association for Cancer Research, Ad Hoc Committee - Public Forum, Chairperson, 1997 – 2008
• American Association for Cancer Research, Ohio State Legislative Committee, 1990-93
• American Association for Cancer Research, Oregon State Legislative Committee, 1993 – 2002
• American Association for Cancer Research, Annual Meeting Committee, 2019 and Multiple Years
• American Association for Cancer Research, NCI Affairs Committee, 1993-96
• American Association for Cancer Research, Ad Hoc Committee on By Laws Revision, 1999
• American Association for Cancer Research, Steering Committee on the War on Cancer, Chairperson, 1998
• American Association for Cancer Research, Rhodes Award Committee, Member, 1990-91
• American Association for Cancer Research, Task Force on Experimental Therapeutics, 1991-93
• American Association for Cancer Research, Annual Meeting Program Committee, Member, 1988-89
• American Association for Cancer Research, Annual Meeting Program Committee, Biology Chairperson, 1989-90
• American Association for Cancer Research, AACR Representative to the National Coalition for American Association for Cancer Research, Cancer Research, 1995 – 2002
• American Association for Cancer Research, Ad Hoc Committee on By Laws Revision, 1999
• American Association for Cancer Research. h Steering Committee on the War on Cancer, Chairperson, 1998
• Fred Hutchinson Cancer Center. External Advisory Board, Member, 1993-1999
• Fred Hutchinson Cancer Center. Molecular Medicine Review Board, Member, 1993-98
• Internal Scientific Review Committee, Member, Riverside Methodist Hospital, 1978-82
• International Congress Reticuloendothelial Society, Resources Committee, Chairperson, 1978
• Ohio State University Cancer Center, Internal Scientific Review Committee, Member, 1976-78
• Oregon Biotechnology Association (OBA), Board of Directors, Member, 1998- 2002
• Oregon Laser Medical Center (OLMC), Board of Directors, Member, Providence/St. Vincent’s Hospital, 1997-2002
• National Cancer Legislative Action (NCLAC) Committee, Member, 2000-2002
• National Coalition for Cancer Research (NCCR), AACR-Representative and Member Board of Directors, 1993-2002
• Ohio Cancer Research Associates, Inc., Scientific Review Committee, Member, 1988-2002
• Ohio Cancer Research Associates, Inc., Board of Trustees, Member, July 1984- 2000
• OXIS International, Inc., Portland, OR, Board of Directors, 1994-1998
• Bioxytech, S.A., Paris, France Chairman, Board of Directors, 1995-1998

Mitchell E. Gross, MD, PhD

• Chair, CTSI Internal Review Panel, 2017-present
• Associate Director, USC-CalTech MD PHD Program
• Member, Data Safety Monitoring Committee, Norris Comprehensive Cancer Center

Kian Kani, PhD 

• Medical School Admissions Interview Panel, Keck School of Medicine of USC, 2017–present

Jerry S.H. Lee, PhD 

• Trustee, Health and Environmental Sciences Institute
• Appointed Member, National Research Advisory Council to the Secretary, Department of Veterans Affairs
• Innovation Initiative Member, Health Services Research and Development Scientific Merit Review Board, Department of Veterans Affairs
• Founding Member, Innovation Policy Forum of the Board on Science, Technology, and Economic Policy, National Academies of Sciences, Engineering, and Medicine (NASEM)
• Co-founder and Co-chair, Blood Profiling Atlas in Cancer (BloodPAC)
• Co-founder and Consultant, Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Research Network, Henry M. Jackson Foundation
• Founding Co-chair, High Content Data Integration Working Group, Biomarkers’ Consortium Cancer Steering Committee, Foundation for the National Institutes of Health
 Advisory Board Member, Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium
• Member, John P. Murtha Cancer Center at the Walter Reed National Military Medical Center
• Trustee, Health and Environmental Sciences Institute, 2015 - present
• Appointed Member, National Research Advisory Council to the Secretary, Department of Veterans Affairs, 2017 - present
• Reviewer (Innovation Initiative), Health Services Research and Development Scientific Merit Review Board, Department of Veterans Affairs, 2018 - present
• Founding Member, Innovation Policy Forum of the Board on Science, Technology, and Economic Policy, National Academies of Sciences, Engineering, and Medicine (NASEM), 2012- 2018
• Deputy Director for Cancer Research and Technology, U.S. White House Cancer Moonshot Task Force, 2016 – 2017
• Member, Data Standards Working Group, Biden Cancer Initiative, 2018 – 2019
• Advisory Board, HESI Thrive, Health and Environmental Sciences Institute, 2018 - present
• Co-founder and Co-chair, Blood Profiling Atlas in Cancer (BloodPAC) Consortium, 2017 - present
• Co-founder and Consultant, Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Research Network, Henry M. Jackson Foundation, 2018 - present
• Founding Co-chair, High Content Data Integration Working Group, Biomarkers’ Consortium Cancer Steering Committee, Foundation for the National Institutes of Health, 2012 - 2018
• Advisory Board Member, Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium, 2019 - present
• Member, John P. Murtha Cancer Center at the Walter Reed National Military Medical Center, 2019 - present



Shannon Mumenthaler, PhD 

• Councilor, Board of Directors, Society for Biomolecular Imaging and Informatics (SBI2), 2019–present
• President, Board of Directors, Medical Faculty Women’s Association Research Fund, 2017–present

Dan Ruderman, PhD

• Consulting Arrangements, Project Ronin, 2019–present
• Consulting Arrangements, Nautilus Biotechnology, 2019–present
• Chief Financial Officer, Smithman Co., 2018–present